ConductScience.org, home

Trial · NCT00674687

A Study Of The Efficacy Of Gabapentin In Neuropathic Pain Patients As Measured By Quantitative Sensory Testing

NCT00674687, Not applicable, Completed, Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. A Study Of The Efficacy Of Gabapentin In Neuropathic Pain Patients As Measured By Quantitative Sensory Testing. Trials, record NCT00674687. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00674687

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
A Study Of The Efficacy Of Gabapentin In Neuropathic Pain Patients As Measured By Quantitative Sensory Testing
NCT number
NCT00674687
Status
Completed
Phases
Not applicable
Enrollment
23 participants, actual
Lead sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions
Neuralgia, Neuralgia, Postherpetic
Interventions
2-weeks placebo then gabapentin, 1-week placebo then gabapentin
First posted
2008-05-08
Last updated
2021-02-02

Source ClinicalTrials.gov

Registered outcomes22

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryPresence/intensity of punctate allodynia (von Frey filament), measured on the pain numeric rating scale (NRS)Weeks 2 and 4
SecondarySubject assessed quality of evoked pain for punctate allodyniaWeeks 2 and 4
SecondaryPain NRS score for temporal summation to dynamic brush allodynia (soft and coarse brush)Weeks 2 and 4
SecondaryPressure pain tolerance thresholdWeeks 2 and 4
SecondaryPain NRS scores for pressure painWeeks 2 and 4
SecondarySubject assessed quality of evoked pain for temporal summation to dynamic brush allodynia (soft and coarse brush)Weeks 2 and 4
SecondaryTactile thresholdWeek 4
SecondaryPressure pain detection thresholdWeeks 2 and 4
SecondaryArea of punctate and dynamic (soft and coarse brush) allodyniaWeeks 2 and 4
SecondaryPain NRS score for punctate allodyniaWeeks 2 and 4

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00674687

GET https://conductscience.org/api/trials/v1/NCT00674687/registered?page=2